Retaglutide and tirzepatide are groundbreaking GLP-1 receptor agonists gaining popularity as effective treatment options for type 2 diabetes. These medications enhance insulin secretion from the pancreas, reduce https://susanmrmk255293.wikicorrespondence.com/6081013/novel_agents_in_diabetes_management